"AItewan" DeepBT Detector has been approved for Class II medical device registration by the Taiwan Food and Drug Administration (TFDA).
DeepBT is a software system intended to assist trained medical professionals during their clinical workflows of radiation therapy treatment planning. DeepBT is applicable only to adult patients with known imaging diagnosis of acoustic neuroma, meningioma, and brain metastasis. The product can take either single parametric magnetic resonance (MR) images (T1W+C) or bi-parametric MR images (T1W+C and T2W) as inputs, then automatically interpret MR images, and provide the lesion contours without requiring manual preprocessing or annotation.
